In a new job - April 20, 2020
Medivir announces departure of Chief Medical Officer
Medivir AB announces that Linda Basse, Chief Medical Officer at Medivir, will leave the company on September 30, 2020. Linda Basse has a PhD in medicine (Copenhagen University) and a Master’s degree in medicine (Copenhagen University). Basse joined Medivir in 2018 and before that she was Medical Director at Genmab, TopoTarget and Zealand Pharma in […]
In a new job - April 20, 2020
Medicon Valley Alliance strengthens its Board of Directors
The Board of Directors of Medicon Valley Alliance (MVA), the Danish-Swedish life science cluster organization, have welcomed new members. At the Ordinary General Meeting, Thursday 16th of April, which was organized as an online meeting, the MVA Board of Directors welcomed Linn Mandahl, General Manager at AbbVie Scandinavia, as a new board member. “It is […]
In a new job - April 14, 2020
Miguel Calado is new Chairman of Nanoform’s Board
Following a one-year succession process, Miguel Calado will succeed Rabbe Klemets, who is moving into an advisory position. Non-executive board member, Mads Laustsen, will assume Calado’s previous role of Vice Chairman. An experienced board member Since joining Nanoform’s board last year as Vice Chairman, Miguel Calado has applied his expertise in strategic business management and […]
In a new job - April 14, 2020
Promore Pharma’s CFO leaves the company
Promore Pharma’s CFO Jenni Björnulfson has announced that she has decided to leave her role in the company for a position in another company. “The Board of Directors and I would like to thank Jenni for her commitment and efforts during the years she has worked for Promore Pharma. It’s sad that Jenni leaves, but […]
In a new job - April 3, 2020
Oncopeptides appoints Global Head of Corporate Communications
Oncopeptides has announced that Rolf Gulliksen has been appointed global head of corporate communications. Rolf Gulliksen has 30 years of experience from senior corporate communications roles in the life science industry and consultancy. Prior to joining Oncopeptides, he served as head of corporate communications at Hansa Biopharma. “Communication will be a critical function to support […]
In a new job - March 31, 2020
Peter Suenaert to resume his role as CMO at Immunicum
Peter Suenaert will resume the role of Chief Medical Officer (CMO) at Immunicum effective May 1st, 2020. As CMO, he will be responsible for the clinical development and strategy for testing ilixadencel in patients with cancer. Due to personal reasons, Suenaert had left this role in Q3 2019 following the completion of the MERECA trial. […]
